34 results about "Abdominal obesity" patented technology

The present invention is directed to a pharmaceutical composition comprised of one or more SGLT-2 inhibitor compound(s) in combination with one or more therapeutic agents which is suitable for the treatment of metabolic disorders including type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance, hyperglycemia, postprandial hyperglycemia, overweight, obesity, including class I obesity, class II obesity, class III obesity, visceral obesity and abdominal obesity, and metabolic syndrome.

The invention provides a compound and application of the compound and the pharmaceutically acceptable salt thereof or a stereo isomer or a prodrug molecule thereof in preparing a medicament for treating or preventing metabolic diseases, wherein the compound has the structural characteristic of a general expression I and is used as a novel fat cell type fatty acid binding protein FABP inhibitor. The compound having the structural characteristic of the general expression I can provide a new selection for the clinical prevention and treatment of the following diseases: 1. type II diabetes, 2. hyperglycemia, 3. hypoglycemia tolerance, 4. insulin resistance, 5. adiposity, 6. lipid turbulence, 7. blood-lipoid imbalance, 8. hyperlipaemia, 9. hypertriglyceridemia, 10. hypercholesterolemia, 11. low high-density protein level, 12. overhigh low-density protein level, 13. atherosclerosis and secondary diseases thereof, 14. hemadostenosis, 15. abdominal obesity, 16. a metabolic syndrome and 17. fatty liver.

The invention relates to a weight losing medicine composition, a preparation containing the medicine composition and a preparation method of the medicine composition, belonging to the technical field of medicines. The weight losing medicine composition comprises the following active ingredients: Indian buead, largehead atractylodes rhizome, pinellia tuber, immature bitter orange, fortune eupatorium herb, rhizoma atractylodis, officinal magnolia bark, rhubarb, radix bupleuri, katsumade galangal seed, lotus leaf, combined spicebush root, cassia bark, safflower, Chinese angelica, white paeony root, Szechuan lovage rhizome, pericarpium zanthoxyli, radix astragali, oriental waterplantain rhizome, villous amomum fruit and capsaicine. A new way is provided for treating obesity, especially abdominal obesity. The weight losing medicine composition and the preparation containing the medicine composition can be used for resolving turbidity and eliminating fullness and preventing and treating complications of obesity, especially abdominal obesity by improving fat metabolism and have the effect of obviously improving abdominal fat accumulation. In particular, the smearing preparation can be locally used and combines with cupping therapy to promote medicine absorption and prolong the duration of the curative effects, and can be used for clinically preventing and treating abdominal obesity and complications thereof.

The invention relates to the field of health care and beauty products and medical instruments, in particular to a belly massager suitable for gastrointestinal motility insufficient patients and abdominal obesity patients. The belly massager can be manufactured in three types which are the single-disc belly massager, the four-disc belly massager and the two-disc belly massager. According to the single-disc belly massager, a motor is connected with a massage shaft component and a massage head component through an eccentric coupler and drive the massage shaft component and the massage head component to rotate, so that a bottom massage disc conducts parallel circular motion, and the belly of a patient is massaged. The four-disc belly massager and the two-disc belly massager are each provided with two gear motors, each motor drives two sets of massage shaft components and massage head components to rotate through a driving gear and a driven gear, and multiple portion massage is achieved. The massage head components can be rapidly detached and installed, and massage heads are convenient to replace. The belly massager is small in size and weight and can be held by hands or tightened through a pull belt to conduct massage, a user operates the belly massager conveniently and freely, and the belly massager has the relatively high use comfort level and massage efficiency.

The invention discloses health care alga agar-agar jelly, which is prepared from the following ingredients in percentage by mass: 1 to 3 percent of dry agar, 10 to 15 percent of fresh caulerpa lentillifera, 5 to 8 percent of traditional Chinese medicine extraction liquid, 0.1 to 0.3 percent of white vinegar and the balance pure water; the traditional Chinese medicine extraction liquid is prepared from the following ingredients in parts by weight: 8 to 10 parts of semen cassiae, 6 to 8 parts of tuckahoe, 10 to 15 parts of rose, 8 to 12 parts of roselle, 6 to 8 parts of Laoshan green tea, 6 to 8 parts of bananas, 10 to 15 parts of strawberries, 15 to 20 parts of smallanthus, 10 to 12 parts of mulberry leaves, 8 to 10 parts of honey-fried licorice roots and 8 to 12 parts of water chestnut. The health care alga agar-agar jelly can be used for treating and preventing abdominal obesity by using methods of soothing the liver and regulating the circulation of qi, clearing the bowels to facilitate feces excretion, and stabilizing and lowering the blood pressure; in addition, the taste is fragrant, sweet and delicious; no obvious alga fishy smell or traditional Chinese medicine bitter taste exists; the weight losing effect can be achieved after the eating for a long time.

The invention discloses a health food for reducing weight, reducing blood pressure, reducing blood-lipid and reducing blood sugar, and a preparation method thereof. The inventive health food comprises, based on the weight part, 5 to 40 parts of black fungus, 5 to 10 parts of konjak and 1 to 6 parts of tuckahoe. On the basis that the natural flavor, colour and nutrient content of black fungus are retained, the preparation combines the traditional dietary cure health preserving formulation with the modern biotechnology, and makes the best of the unique bidirectional adjusting technic in Chinesemedicine. After people orally take the black fungus beverage and black fungus capsule prepared by the invention, the metabolite in the cardiovascular system and gastrointestinal tract system of the body can be cleaned up, the endocrine system can be adjusted, and the stable ability of the inner environment of body can be enhanced, and the nutritional and metabolic disease can be prevented. The black fungus beverage and black fungus capsule prepared by the invention have the special effect for the prevention and auxiliary treatment of the metabolic chronic disease such as insulin resistance and the like, especially for abdominal obesity.

The present invention is one kind of chair, which has one inclined seat with lower front part and higher back part, and one abdomen rest connected to the seat, the pedestal, the tray or the arm rest to support the abdomen. The chair with abdomen rest makes the person in the chair in excellent physiological state, and can remit fatigue and inhibit abdominal obesity. The present invention is especially suitable for staff, student and computer operator.

The invention relates to the technical field of massage, and discloses automatic massage apparatus for gastrointestinal diseases or abdominal obesity. The automatic massage apparatus comprises a mounting box, wherein the left and right sides of the mounting box are fixedly connected with waist belts, a position-limiting plate and a motor are respectively arranged inside the mounting box, the edgeof the position-limiting plate is fixedly connected with slide rails, an output end of the motor is movably connected with a central gear, the tooth edge of the central gear is in mesh connection withtransmission gears, the surface of each transmission gear is fixedly connected with a driving wheel, and the wheel edge of each driving wheel is movably connected with one end of a corresponding transmission belt. According to the automatic massage apparatus for gastrointestinal diseases or abdominal obesity, the central gear is driven to rotate through the motor, position-limiting blocks are indirectly driven to squeeze a massage airbag in a reciprocating manner, the airbag is repeatedly contracted and expanded to massage the abdomen of a user, spring rods and the position-limiting plate arecooperatively arranged for buffering and position-limiting, the massage force is prevented from being too large or too small, and thereby the effect of automatically pressing the abdomen and stabilizing the massage force is achieved.

The invention relates to a traditional Chinese medicine composition for reducing body fat mass and treating abdominal obesity. The traditional Chinese medicine composition is prepared from the following crude drugs in parts by weight: 2-4 parts of rhizoma coptidis, 1-3 parts of radix scutellariae, 1-3 parts of rhizoma polygoni cuspidati, 1-3 parts of radix lithospermi, 1-3 parts of honeysuckle flower, 2-4 parts of rhizoma atractylodis and 1-3 parts of lotus leaf. The traditional Chinese medicine composition is only prepared from the seven medicines, thus being fewer in medicines, low in priceand simple to prepare; the traditional Chinese medicine composition can be used for treating the abdominal obesity and reducing the body fat mass as well as improving the body fat distribution of patients and relieving leptin resistance, and is a safe and effective fat-reducing medicine.

The invention discloses a traditional Chinese medicine acupoint application formula for abdominal obesity as well as a preparation method and application of the traditional Chinese medicine acupoint application formula. The traditional Chinese medicine acupoint application formula is characterized by comprising the following components in parts by weight: 18-22 parts of rhizoma coptidis, 18-22 parts of radix et rhizoma rhei, 18-22 parts of radix scutellariae, 18-22 parts of cortex phellodendri, 18-22 parts of poria cocos, 18-22 parts of fructus aurantii immaturus, 18-22 parts of myrrh, 15-18 parts of radix phytolaccae and 8-12 parts of radix glycyrrhizae. The medicine disclosed by the invention has effects of promoting QI circulation, tonifying the spleen, clearing heat, promoting diuresis, dissolving turbidity and the like, and the traditional Chinese medicine acupoint application prepared from the medicine has a good curative effect on abdominal obesity. The medicine has an obvious effect after being applied to the acupoint for 7-14 days. Clinical observation shows that the effect is better when the acupoint application time is prolonged.

The invention belongs to the field of oral liquid preparation, and mainly relates to collagen peptide oral liquid and a preparation method thereof. Specifically, every 100 mL of the collagen peptide oral liquid comprises the following components in percentage by mass: 5 to 15 percent of collagen peptide, 15 to 20 percent of a sweetening agent, 0.1 to 0.3 percent of malic acid, 0.3 to 1 percent of rose pollen, 0.05 to 0.3 percent of aronia juice powder, 0.2 to 0.7 percent of pomegranate juice powder, 0.02 to 0.05 percent of a saffron crocus extract and 65 to 75 percent of water. The collagen peptide oral liquid is rich in flower fragrance, rich in sour and sweet taste, good in stability and long in shelf life, can remarkably improve measurement indexes and lipid conditions of women with abdominal obesity, and improves the sleep quality of women and relieves anxiety to a certain extent.

A composition for prevention and treatment of metabolic syndromes is composed of radix astragali preparata, rhizoma polygonati, mulberry fruits, yam, fructus crataegi, lotus leaves, cassia seeds, phaseolus calcaratus, poria cocos, endothelium corneum gigeriae galli, fructus amomi, dandelions and the like. It is verified that the composition has the functions of relieving and preventing the metabolic syndromes such as abdominal obesity, dyslipidemia and abnormal glucose metabolism.

The invention relates to traditional Chinese medicine composition for patients with syndrome of interior dampness-heat and abdominal obesity and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from raw materials in parts by weight as follows: 25-35 parts of poria cocos extract, 25-35 parts of rhodiola, 25-35 parts of folium nelumbinis, 25-35 parts of herba gynostemmae, 10-20 parts of rhizoma coptidis, 10-20 parts of bulbus fritillariae thunbergii, 10-20 parts of radix salviae miltiorrhizae, 10-20 parts of pericarpium citri reticulatae, 10-15 parts of rhizoma pinelliae preparatum, 5-15 parts of stir-baked caulis bambusae in taeniam with ginger juice, 5-15 parts of bile arisaema and 5-15 parts of fructus amomi. The traditional Chinese medicine composition can specifically induce diuresis, clear dampness, clear away heat and purge pathogenic fire and has functions of comprehensively conditioning qi and blood, tonifying the spleen and nourishing the stomach, and phlegm-dampness in the body is dispelled, so that the syndrome of interior dampness-heat and the abdominal obesity are treated fundamentally; and according to the preparation method, all that is required is to crush and mix the raw materials, the process is simple and controllable, and large-scale production is facilitated.

The invention discloses procyanidine-containing prebiotics and application thereof to obesity and metabolic syndrome medicines. The prebiotics take procyanidine as the main active ingredient. Procyanidine can improve the obesity and metabolic syndromes through wholly or partially depending on intestinal flora regulation. The relationship between GSPE and intestinal flora, inflammation and metabolism is creatively established for the first time to testify that the metabolism improvement function of GSPE wholly or partially depends on the intestinal flora. GSPE can serve as a brand-new prebiotics to be used for improving the obesity and metabolic syndromes of hosts, particularly abdominal obesity and 2-type diabetes.

The invention relates to the technical field of navel treatment, and discloses navel electrothermal powder, and an application method and device thereof. The navel electrothermal powder is mainly prepared by crushing of radix astragali, safflowers, rhizoma corydalis, rhizoma ligustici wallichii, apocynum venetum, common selfheal fruit-spike, caulis polygoni multiflori, platycodon roots, radix stemonae, common coltsfoot flower and licorice roots. The navel electrothermal powder disclosed by the invention can effectively prevent and treat abdominal obesity/central obesity and prevent and treat symptoms including flatulence, indigestion, lower abdomen cold pain, dysmenorrhea, menstrual period lumbago, cold hands and feet, limb drowsiness, fatigue and weakness, cough, asthma and the like caused by the abdominal obesity/central obesity, and has the characteristic of being free from infusion, free from injection, free from medicine taking, free from acupuncture and moxibustion, free from cupping, free from skin scraping therapy, and simple and convenient to operate; and besides, oral administration is not needed, so that damage of traditional Chinese medicines to the liver is avoided and reduced; trouble and discomfort in mouth feel caused by decocting medicines and taking medicines orally do not exist; the navel electrothermal powder can be repeatedly used, so that the medicine purchasing cost can be effectively reduced, time and temperature of hot compressing can be autonomously and easily controlled, and the operation is convenient, simple and practicable.

The invention relates to a method and device for the in vitro detection of polycystic ovary syndrome (PCOS) and pathologies involving cardiovascular risk. An in vitro assay method and assay device (kit) for the diagnosis of the presence or the predisposition to suffer from PCOS and/or cardiovascular risk factors including: general obesity, abdominal obesity, hypertension, glucose intolerance, diabetes, hyperinsulinemia, general hypercholesterolemia, hypercholesterolemia with high LDL-cholesterol levels, low HDL-cholesterol levels and hypertriglyceridemia, as well as the grouping of some of these cardiovascular risk factors known as metabolic syndrome. The method and the kit are characterized in that they are based on the detection of at least one genotype or haplotype of a polymorphism in the CAPN5 gene selected from: Nt g.86 A>G, Nt g.344 G>A, Nt c.1320 C>T and Nt c.1469 G>A or combinations thereof.

The invention relates to the technical field of medicines, in particular to injection for treating premature ovarian failure. The injection comprises 50 to 200 milligrams of flavone, 10 to 30 milligrams of Vitb6, 1.8 to 3.2 grams of glutathione, and 3 to 8 grams of Vit c. The injection enters human body by injecting, is directly absorbed, can effectively and lastingly activate the functions of ovarian cells, repair special nutritional substances of atrophic ovary, promote female hormone balance, improve climacteric symptoms and particularly improve secretion of female hormone and progestogen, and has a remarkable curative effect; the injection is used for comprehensively conditioning various symptoms caused by female endocrine dyscrasia, and has remarkable effects of improving the immunity of the body, preventing osteoporosis and quickly eliminating the symptoms such as hot flash, hidrosis, insomnia, dysphoria, waist soreness, backache, menstrual disorder, skin stain and lumbar and abdominal obesity; and the injection avoids risks and potential safety hazards caused by estradiol in conventional therapy.

Compounds, compositions and methods are provided for mitochondrial modulation. The subject mitochondrial modulator compounds generally include a head group linked to a charged moiety. In certain cases, the head group is a heterocyclic or a heteroaryl group. Aspects of the subject methods include a method of modulating mitochondria. Aspects of the subject methods include treating a subject having a metabolic syndrome-related disease or a symptom thereof by administering to the subject a therapeutically effective amount of a subject compound. In certain cases, the disease is selected from hyperlipidemia, type 2 diabetes, fatty liver disease, obesity, cardiovascular disease and stroke. In certain cases, the symptom is selected from abdominal obesity, insulin resistance, hyperinsulinemia, high levels of blood fats, increased blood pressure, and elevated serum lipids.

The invention relates to the technical field of traditional Chinese medicine and discloses a compound preparation for improving a metabolic syndrome and a preparation method and application of the compound preparation for improving the metabolic syndrome. The technical scheme is characterized in that the compound preparation is prepared from, by mass, 30 parts of rhizoma curcumae longae, 20 partsof semen raphani, 25 parts of rhizoma et herba helianthi tuberose and 25 parts of radix et rhizoma rhodiolae. The preparation method includes; taking traditional Chinese medicinal materials as raw materials, preparing dry extract according to a water and ethyl alcohol mixed solution extract method, and further preparing to obtain a granular compound preparation. The compound preparation or a pharmaceutically-acceptable drug carrier thereof can be applied to preparation of a pharmaceutical preparation for improving the metabolic syndrome and especially applicable to preparation of a pharmaceutical preparation for improving abdominal obesity, type-2 diabetes, hyperlipidaemia or atherosclerosis. By synergistic effects of the medicinal materials, blood glucose reducing, blood fat reducing andanti-obesity functions are remarkable, and no side effect is caused.